Sweet K, Bhatnagar B, Dohner H, Donnellan W, et al. A 2:1 randomized, open-label, phase II study of selinexor vs. physician's choice in older patients with relapsed or refractory acute myeloid leukemia. Leuk Lymphoma 2021 Jul 29:1-12. doi: 10.1080/10428194.2021.1950706.
PMID: 34323164